| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ARNO THERAPEUTIC INC | 2,034,721 | 3,621,000 | 0.36% | ||
| 52 | APPLIED GENETIC TECHNOL CORP | 146,978 | 3,395,000 | 0.33% | ||
| 53 | CHIMERIX INC | 148,000 | 3,241,000 | 0.32% | ||
| 54 | AEGERION PHARMACEUTICALS INC | 100,000 | 3,209,000 | 0.31% | Call | |
| 55 | TESARO INCORPORATED | 100,000 | 3,111,000 | 0.31% | Put | |
| 56 | ZELTIQ AESTHETICS INC | 201,628 | 3,065,000 | 0.30% | ||
| 57 | VERTEX PHARMACEUTICALS INC | 30,000 | 2,840,000 | 0.28% | Put | |
| 58 | MGC DIAGNOSTICS CORP | 316,459 | 2,652,000 | 0.26% | ||
| 59 | QUOTIENT LTD | 300,000 | 2,499,000 | 0.25% | ||
| 60 | ACASTI PHARMA INC | 2,566,785 | 2,437,000 | 0.24% | ||
| 61 | FIVE PRIME THERAPEUTICS INC | 150,000 | 2,333,000 | 0.23% | ||
| 62 | COVIDIEN PLC | 25,000 | 2,255,000 | 0.22% | ||
| 63 | KARYOPHARM THERAPEUTICS INC COM | 45,643 | 2,125,000 | 0.21% | ||
| 64 | ACHILLION PHARMACEUTICALS IN | 280,000 | 2,120,000 | 0.21% | ||
| 65 | GENVEC INC | 820,000 | 2,107,000 | 0.21% | ||
| 66 | SMITH & NEPHEW PLC | 22,963 | 2,050,000 | 0.20% | ||
| 67 | UROPLASTY INC | 668,287 | 1,791,000 | 0.18% | ||
| 68 | LIGAND PHARMACEUTICALS INC | 27,843 | 1,734,000 | 0.17% | ||
| 69 | DURECT CORP | 907,064 | 1,651,000 | 0.16% | ||
| 70 | CHAMPIONS ONCOLOGY | 1,625,744 | 1,625,000 | 0.16% | ||
| 71 | ANTHERA PHARMACEUTICALS INC | 478,456 | 1,622,000 | 0.16% | ||
| 72 | OREXIGEN THERAPEUTICS INC COM | 224,000 | 1,384,000 | 0.14% | ||
| 73 | EXELIXIS INC | 400,000 | 1,356,000 | 0.13% | Call | |
| 74 | NEWLINK GENETICS CORP COM | 50,000 | 1,328,000 | 0.13% | Call | |
| 75 | EPIZYME INC COM | 42,602 | 1,326,000 | 0.13% | ||
| 76 | AQUINOX PHARMACEUTICALS INC | 130,000 | 1,218,000 | 0.12% | ||
| 77 | SYNERON MEDICAL LTD | 115,000 | 1,187,000 | 0.12% | ||
| 78 | INCYTE CORP | 20,000 | 1,129,000 | 0.11% | ||
| 79 | ATHERSYS INC NEW | 601,852 | 1,077,000 | 0.11% | ||
| 80 | OXIGENE INC | 379,200 | 982,000 | 0.10% | ||
| 81 | ICAD INC | 150,000 | 962,000 | 0.09% | ||
| 82 | ONCOTHYREON INC COM N/C EFF 6/ | 292,779 | 949,000 | 0.09% | ||
| 83 | ACHAOGEN INC COM | 60,000 | 838,000 | 0.08% | ||
| 84 | GALMED PHARMACEUTICALS LTD | 75,000 | 731,000 | 0.07% | ||
| 85 | BIOTA PHARMACEUTIALS INC COM | 253,400 | 722,000 | 0.07% | ||
| 86 | TRANSGENOMIC INC COM NEW | 183,957 | 687,000 | 0.07% | ||
| 87 | STEMCELLS INC COM NEW | 271,600 | 551,000 | 0.05% | ||
| 88 | CLOVIS ONCOLOGY INC | 10,917 | 452,000 | 0.04% | ||
| 89 | MEDGENICS INC | 55,073 | 428,000 | 0.04% | ||
| 90 | BIOLINERX LTD | 165,698 | 345,000 | 0.03% | ||
| 91 | HEALTH NET INC | 6,025 | 250,000 | 0.02% | ||
| 92 | UNIVERSAL HLTH SVCS INC | 2,236 | 214,000 | 0.02% | ||
| 93 | Arena Pharmaceuticals, Inc | 30,000 | 176,000 | 0.02% | Put | |
| 94 | RADNET INC COM | 22,975 | 152,000 | 0.01% | ||
| 95 | SUNSHINE HEART INC | 25,000 | 140,000 | 0.01% | ||
| 96 | ICON PLC | 2,440 | 115,000 | 0.01% | ||
| 97 | Exactech Inc | 4,464 | 113,000 | 0.01% | ||
| 98 | ENSIGN GROUP INC | 3,509 | 109,000 | 0.01% | ||
| 99 | CHINA BIOLOGIC PRODS INC | 2,400 | 107,000 | 0.01% | ||
| 100 | GENTIVA HEALTH SER | 7,052 | 106,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-14-001053, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
